You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Clovis

Showing 26 - 50 of 139
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Germany (Rucaparib, Placebos)

Recruiting
  • Ovarian Cancer
  • +3 more
  • Berlin, Germany
  • +22 more
Aug 30, 2021

Metastatic Castration-Resistant Prostate Cancer, Ovarian Cancer, Epithelial Ovarian Cancer Trial in Worldwide (Rucaparib)

Enrolling by invitation
  • Metastatic Castration-Resistant Prostate Cancer
  • +5 more
  • Lakewood, Colorado
  • +37 more
Jan 18, 2022

Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +43 more
Nov 17, 2022

Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)

Recruiting
  • Cancer
  • +3 more
  • Amersfoort, Utrecht, Netherlands
  • +34 more
Oct 26, 2021

Tolerability of Lenvatinib in Advanced or Unresectable

Recruiting
  • Carcinoma, Hepatocellular
  • Clovis, California
  • +48 more
Aug 12, 2022

Adenocarcinoma of the Oesophagus, Adenocarcinoma of the Gastro-oesophageal Junction, Adenocarcinoma of the Stomach Trial in

Recruiting
  • Adenocarcinoma of the Oesophagus
  • +2 more
  • Sutton, United Kingdom
    The Royal Marsden NHS Foundation Trust, Downs Road, Sutton
Feb 19, 2020

Gastric Cancer, Cancer of the Stomach, Esophagogastric Junction Trial in Worldwide (BMS-986213, Nivolumab, XELOX)

Active, not recruiting
Has Results
  • Gastric Cancer
  • +2 more
  • BMS-986213
  • +4 more
  • Clovis, California
  • +77 more
Jan 9, 2023

Solid Tumor Trial in United States (68Ga-FAP-2286, 177Lu-FAP-2286)

Recruiting
  • Solid Tumor
  • Birmingham, Alabama
  • +5 more
Aug 26, 2022

Postherpetic Neuralgia Trial in United States (pregabalin, pregabalin/PF-00489791, Placebo)

Completed
Has Results
  • Postherpetic Neuralgia
  • Huntsville, Alabama
  • +38 more
Aug 4, 2021

Advanced Solid Tumor, Gynecologic Cancer Trial in Worldwide (Lucitanib, Nivolumab)

Suspended
  • Advanced Solid Tumor
  • Gynecologic Cancer
  • Los Angeles, California
  • +26 more
Dec 16, 2022

Advanced Solid Tumor Trial in Akashi, Hidaka, Tsukiji (Rucaparib)

Completed
  • Advanced Solid Tumor
  • Akashi, Hyogo, Japan
  • +2 more
May 16, 2022

Sjogren's Syndrome Trial in Reims (Evaluation of olfactory function, Evaluation of taste function, Evaluation of (intra-nasal

Not yet recruiting
  • Sjogren's Syndrome
  • Evaluation of olfactory function
  • +2 more
  • Reims, France
    Université de Reims Champagne-Ardenne
May 24, 2022

Metastatic Castration Resistant Prostate Cancer Trial in Atlanta, Minneapolis, Nashville (Rucaparib, Enzalutamide, Abiraterone)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Atlanta, Georgia
  • +2 more
Jan 24, 2022

Metastatic Castration Resistant Prostate Cancer Trial in Worldwide (Rucaparib, Abiraterone acetate or Enzalutamide or Docetaxel)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Rucaparib
  • Abiraterone acetate or Enzalutamide or Docetaxel
  • Birmingham, Alabama
  • +149 more
Jan 19, 2023

Moderate to Severe Atopic Dermatitis Trial in Worldwide (ISB 830 - Part 1 Group 1, ISB 830 - Part 1 Group 2, ISB 830 - Part 1

Completed
Has Results
  • Moderate to Severe Atopic Dermatitis
  • ISB 830 - Part 1 Group 1
  • +5 more
  • Birmingham, Alabama
  • +82 more
Jul 26, 2022

Tumors Trial in Poland, Slovakia, United Kingdom (Rucaparib camsylate)

Completed
  • Neoplasms
  • Rucaparib camsylate
  • Biała Podlaska, Poland
  • +5 more
Oct 26, 2021

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Trial in Israel, United States (Blinatumomab,

Recruiting
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Blinatumomab
  • +10 more
  • Anchorage, Alaska
  • +152 more
Aug 11, 2022

Ovarian Cancer Trial in Worldwide (VS-6766, VS-6766 and Defactinib)

Recruiting
  • Low Grade Ovarian Serous Adenocarcinoma
  • Ovarian Cancer
  • avutometinib (VS-6766)
  • avutometinib (VS-6766) and Defactinib
  • Scottsdale, Arizona
  • +46 more
Dec 29, 2022

Systemic Juvenile Idiopathic Arthritis Trial in Worldwide (Baricitinib, Placebo)

Recruiting
  • Systemic Juvenile Idiopathic Arthritis
  • Rosario, Santa Fe, Argentina
  • +65 more
Jan 18, 2023

Endometrial Endometrioid Adenocarcinoma, Stage I Uterine Corpus Cancer AJCC v8, Stage IA Uterine Corpus Cancer AJCC v8 Trial in

Active, not recruiting
  • Endometrial Endometrioid Adenocarcinoma
  • +4 more
  • Brachytherapy
  • +4 more
  • Birmingham, Alabama
  • +277 more
Sep 16, 2022

Metastatic Castration Resistant Prostate Cancer Trial in Worldwide (Rucaparib)

Completed
Has Results
  • Metastatic Castration Resistant Prostate Cancer
  • Birmingham, Alabama
  • +148 more
Jun 14, 2022

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in Worldwide (Oral rucaparib)

Completed
Has Results
  • Ovarian Cancer
  • +3 more
  • Oral rucaparib
  • Anchorage, Alaska
  • +74 more
Jan 31, 2022

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in Worldwide (Chemotherapy, Rucaparib)

Active, not recruiting
Has Results
  • Ovarian Cancer
  • +3 more
  • Denver, Colorado
  • +76 more
Feb 20, 2022

Post Herpetic Neuralgia Trial in Worldwide (Pregabalin, )

Completed
Has Results
  • Post Herpetic Neuralgia
  • Gulf Shores, Alabama
  • +145 more
Jan 26, 2021

Advanced Colorectal Cancer, Metastatic Colorectal Cancer Trial in Worldwide (MRTX849, Cetuximab, mFOLFOX6 Regimen)

Recruiting
  • Advanced Colorectal Cancer
  • Metastatic Colorectal Cancer
  • Birmingham, Alabama
  • +208 more
Aug 3, 2022